日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer.

肿瘤微环境中的 CD8+ T 细胞调节乳腺癌对内分泌治疗的反应。

Napolitano Fabiana, Wang Yunguan, Sudhan Dhivya R, Gonzalez-Ericsson Paula I, Formisano Luigi, Unni Nisha, Shakeel Shahbano, Zhu James Z, Ahuja Khushi, Guo Lei, Chica-Parrado María Rosario, Matsunaga Yuki, Luna Pamela, Lin Chang-Ching A, Uemoto Yasuaki, Lee Kyung-Min, Ma Hongli, Evans Nathaniel J, Servetto Alberto, Mendiratta Saurabh, Barnes Spencer D, Bianco Roberto, Fang Yisheng V, Xu Lin, Lee Jeon, Wang Tao, Balko Justin M, Mills Gordon B, Labrie Marilyne, Hanker Ariella B, Arteaga Carlos L

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer.

从临床到实验室的转化分析:激素受体阳性转移性乳腺癌中 NF1 改变和 CDK4/6 抑制剂耐药性

Lloyd Maxwell R, Chica-Parrado Rosario, Weipert Caroline M, Knepper Todd C, Podany Emily L, Napolitano Fabiana, Ye Dan, Lin Chang-Ching, Uemoto Yasuaki, Liao Jiemin, Wegrzyn Claire, Walko Christine M, Ryan Lianne Y, Keenan Jennifer C, Medford Arielle J, Liu Shiyuan A, Wulf Gerburg M, Clifton Katherine K, Ma Cynthia X, Han Hyo S, Zhang Nicole, Ellisen Leif W, Bardia Aditya, Arteaga Carlos L, Hanker Ariella B, Wander Seth A

ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer.

ESR1 Y537S 和 D538G 突变导致雌激素受体阳性乳腺癌对 CDK4/6 抑制剂产生耐药性

Lin Chang-Ching A, Chica-Parrado María Rosario, Unni Nisha, Jaeger Ellen, Fang Yisheng V, Guo Lei, Napolitano Fabiana, Luna Pamela, Harris Michelle, Chao Calvin, Xu Lin, Arteaga Carlos L, Hanker Ariella B

Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations.

选择性降解 FGFR1/2 可克服 FGFR1/2 改变的 ER+ 乳腺癌的抗雌激素耐药性

Uemoto Yasuaki, Lin Chang-Ching A, Wang Bingnan, Ye Dan, Fang Yisheng V, Bikorimana Emmanuel, Napolitano Fabiana, Chica-Parrado Maria Rosario, Li Cheung, Mendiratta Saurabh, Chen Chuo, Hanker Ariella B, Arteaga Carlos L

AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer

AXL/WRNIP1介导复制应激反应,并促进HER2阳性乳腺癌的治疗耐药性和异时性转移

Mauricio Marquez-Palencia ,Luis Reza Herrera ,Pravat Kumar Parida ,Suvranil Ghosh ,Kangsan Kim ,Nikitha M Das ,Paula I Gonzalez-Ericsson ,Melinda E Sanders ,Bret C Mobley ,Sebastian Diegeler ,Todd A Aguilera ,Yan Peng ,Cheryl M Lewis ,Carlos L Arteaga ,Ariella B Hanker ,Angelique W Whitehurst ,James B Lorens ,Rolf A Brekken ,Anthony J Davis ,Srinivas Malladi

Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer.

CDK4/6 和 AKT 的联合抑制对三阴性乳腺癌的管腔雄激素受体 (LAR) 亚型具有高度疗效

Chica-Parrado María Rosario, Kim Gun Min, Uemoto Yasuaki, Napolitano Fabiana, Lin Chang-Ching, Ye Dan, Bikorimana Emmanuel, Fang Yisheng, Lee Kyung-Min, Mendiratta Saurabh, Hanker Ariella B, Arteaga Carlos L

Evaluating the immunologically "cold" tumor microenvironment after treatment with immune checkpoint inhibitors utilizing PET imaging of CD4 + and CD8 + T cells in breast cancer mouse models

利用乳腺癌小鼠模型中 CD4 + 和 CD8 + T 细胞的 PET 成像评估免疫检查点抑制剂治疗后的免疫“冷”肿瘤微环境

Yun Lu, Hailey A Houson, Carlos A Gallegos, Alessandro Mascioni, Fang Jia, Argin Aivazian, Patrick N Song, Shannon E Lynch, Tiara S Napier, Ameer Mansur, Benjamin M Larimer, Suzanne E Lapi, Ariella B Hanker, Anna G Sorace

Mapping Cellular Interactions from Spatially Resolved Transcriptomics Data

利用空间分辨转录组学数据绘制细胞相互作用图谱

Zhu, James; Wang, Yunguan; Chang, Woo Yong; Malewska, Alicia; Napolitano, Fabiana; Gahan, Jeffrey C; Unni, Nisha; Zhao, Min; Yuan, Rongqing; Wu, Fangjiang; Yue, Lauren; Guo, Lei; Zhao, Zhuo; Chen, Danny Z; Hannan, Raquibul; Zhang, Siyuan; Xiao, Guanghua; Mu, Ping; Hanker, Ariella B; Strand, Douglas; Arteaga, Carlos L; Desai, Neil; Wang, Xinlei; Xie, Yang; Wang, Tao

Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases

通过靶向DRP1限制线粒体可塑性可诱导代谢重编程并减少乳腺癌脑转移

Pravat Kumar Parida ,Mauricio Marquez-Palencia ,Suvranil Ghosh ,Nitin Khandelwal ,Kangsan Kim ,Vidhya Nair ,Xiao-Zheng Liu ,Hieu S Vu ,Lauren G Zacharias ,Paula I Gonzalez-Ericsson ,Melinda E Sanders ,Bret C Mobley ,Jeffrey G McDonald ,Andrew Lemoff ,Yan Peng ,Cheryl Lewis ,Gonçalo Vale ,Nils Halberg ,Carlos L Arteaga ,Ariella B Hanker ,Ralph J DeBerardinis ,Srinivas Malladi

Acquired Secondary HER2 Mutations Enhance HER2/MAPK Signaling and Promote Resistance to HER2 Kinase Inhibition in Breast Cancer

获得性继发性 HER2 突变增强 HER2/MAPK 信号传导并促进乳腺癌对 HER2 激酶抑制的耐药性

Arnaldo Marín #, Abdullah Al Mamun #, Hima Patel, Hiroaki Akamatsu, Dan Ye, Dhivya R Sudhan, Lisa Eli, Katherine Marcelain, Benjamin P Brown, Jens Meiler, Carlos L Arteaga, Ariella B Hanker